Abstract

The therapeutic value of adipose-derived mesenchymal stem cells (Ad-MSCs) for bone regeneration is critically discussed. A possible reason for reduced osteogenic potential may be an age-related deterioration of the Ad-MSCs. In long term in vitro culture, epigenomic changes in DNA methylation are known to cause gene silencing, affecting stem cell growth as well as the differentiation potential. In this study, we observed an age-related decline in proliferation of primary human Ad-MSCs. Decreased Nanog, Oct4 and Lin28A and increased Sox2 gene-expression was accompanied by an impaired osteogenic differentiation potential of Ad-MSCs isolated from old donors (>60 a) as compared to Ad-MSCs isolated from younger donors (<45 a). 5-hydroxymethylcytosine (5 hmC) and 5-methylcytonsine (5 mC) distribution as well as TET gene expression were evaluated to assess the evidence of active DNA demethylation. We observed a decrease of 5 hmC in Ad-MSCs from older donors. Incubation of these cells with 5-Azacytidine induced proliferation and improved the osteogenic differentiation potential in these cells. The increase in AP activity and matrix mineralization was associated with an increased presence of 5 hmC as well as with an increased TET2 and TET3 gene expression. Our data show, for the first time, a decrease of DNA hydroxymethylation in Ad-MSCs which correlates with donor-age and that treatment with 5-Azacytidine provides an approach which could be used to rejuvenate Ad-MSCs from aged donors.

Highlights

  • Extensive bone loss after trauma or diseases often results in delayed or impaired bone healing [1]

  • Expression of Ki67 was significantly lower in adipose-derived mesenchymal stem cells (Ad-mesenchymal stem cells (MSCs)) isolated from aged donors as compared to Ad-MSCs isolated from younger donors, representing an impaired proliferation capacity of Ad-MSCs from elderly donors

  • In order to evaluate the differentiation potential, Ad-MSCs were differentiated for 14 days in the presence of osteogenic differentiation medium

Read more

Summary

Introduction

Extensive bone loss after trauma or diseases often results in delayed or impaired bone healing [1]. Deteriorated bone regeneration and repair is observed with increasing age of patients [1,2]. In vitro experiments demonstrated an active self-renewal capacity and multi-lineage differentiation potential of MSCs [6,7]. MSCs can be isolated from various tissues; most frequently from adipose tissue and bone marrow. It has been reported many times that adult stem cells, including MSCs, suffer from a decline in stem cell function with increasing age during long term culture of the cells [10,11]. The decline observed in the self-renewal capacity, resulted in an incomplete differentiation into the committed cell lineage [12]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.